On November 12, 2013, the Board of Directors (the "Board") approved, and the stockholders of Aramark adopted by written consent, the Aramark 2013 Stock Incentive Plan (the "Old 2013 Stock Plan"), which became effective on December 1, 2013 and the amended and restated Old 2013 Stock Plan was approved by the Board on November 9, 2016 and approved by the stockholders of Aramark on February 1, 2017 (as amended, the "2013 Stock Plan"). The 2013 Stock Plan provides that the total number of shares of common stock that may be issued under the 2013 Stock Plan is 25,500,000.

The following table summarizes the share-based compensation expense and related information for Time-Based Options ("TBOs"), Performance-Based Options ("PBOs"), Time-Based Restricted Stock Units ("RSUs"), Performance Stock Units and Performance Restricted Stock ("PSUs"), and Deferred Stock Units classified as "Selling and general corporate expenses" in the Consolidated Statements of Income (in millions).



	Fiscal Year Ended
	September 27, 2019		September 28, 2018		September 29, 2017
TBOs	$	14.7	$	18.5	$	20.4
RSUs	28.9		24.1		20.8
PSUs ⁽¹⁾	9.9		43.7		21.6
Deferred Stock Units	1.8		2.0		2.4
	$	55.3	$	88.3	$	65.2

Taxes related to share-based compensation	$	13.7	$	24.1	$	24.2
Cash Received from Option Exercises	39.1		21.5		28.8
Tax Benefit on Share Deliveries ⁽²⁾	4.8		7.4		23.3



(1)	Share-based compensation expense was reduced during fiscal 2019 based on lower than estimated target attainment on plan metrics for the fiscal 2018 PSU grants, resulting in the reversal of previously recognized share-based compensation expense of $6.6 million. The Company also reversed previously recognized share-based compensation expense based on the actual target for the 2017 PSU grants achieved as of the end of fiscal 2019 of $5.2 million. During fiscal 2018, the Company increased the estimated target attainment on plan metrics for both the fiscal 2016 and fiscal 2017 PSU grants, resulting in an additional $18.9 million of share-based compensation expense.
(2)	The tax benefit on option exercises and restricted stock unit deliveries is included in "Accrued Expenses" in the Consolidated Statements of Cash Flows.

No compensation expense was capitalized. Prior to the fourth quarter of fiscal 2018, the Company has applied a forfeiture assumption of 8.7% per annum in the calculation of such expenses. The rate was reduced to approximately 6.4% per annum in the fourth quarter of fiscal 2018 based on actual forfeiture activity.

The fair value of the TBOs granted was estimated using the Black-Scholes option pricing model. The expected volatility is based on a blended average of the historical volatility of the Company's and competitors' stocks over the expected term of the stock options. The expected life represents the period of time that options granted are expected to be outstanding and is calculated using the simplified method as permitted under Securities and Exchange Commission ("SEC") rules and regulations due to the method providing a reasonable estimate in comparison to actual experience. The simplified method uses the midpoint between an option's vesting date and contractual term. The risk-free rate is based on the United States Treasury security with terms equal to the expected life of the option as of the grant date. Compensation expense for TBOs is recognized on a straight-line basis over the vesting period during which employees perform related services.



	Fiscal Year Ended
	September 27, 2019	September 28, 2018	September 29, 2017
Expected volatility	20%	20%	25%
Expected dividend yield	1.17% - 1.44%	1.03% - 1.11%	1.11% - 1.21%
Expected life (in years)	6.25	6.25	6.25
Risk-free interest rate	1.62% - 3.02%	2.25% - 2.94%	2.14% - 2.20%
Weighted-average grant-date fair value	$8.23	$8.75	$8.47

A summary of TBO activity is presented below:



Options	Shares (000s)		Weighted-Average Exercise Price		Aggregate Intrinsic Value ($000s)		Weighted-Average Remaining Term (Years)
Outstanding at September 28, 2018	13,302		$	26.60
Granted	1,955		$	36.42
Exercised	(1,973	)	$	21.90
Forfeited and expired	(928	)	$	35.72
Outstanding at September 27, 2019	12,356		$	28.22	$	182,889	5.7
Exercisable at September 27, 2019	8,150		$	23.82	$	156,493	4.4
Expected to vest at September 27, 2019	3,980		$	36.72	$	25,066	8.2



	Fiscal Year Ended
	September 27, 2019		September 28, 2018		September 29, 2017
Total intrinsic value exercised (in millions)	$	26.8	$	16.6	$	32.2
Total fair value that vested (in millions)	16.3		17.3		17.7

A summary of PBO activity is presented below:



Options	Shares (000s)		Weighted-Average Exercise Price		Aggregate Intrinsic Value ($000s)		Weighted-Average Remaining Term (Years)
Outstanding at September 28, 2018	1,875		$	12.46
Granted	—		$	—
Exercised	(364	)	$	11.17
Forfeited and expired	—		$	—
Outstanding at September 27, 2019	1,511		$	12.77	$	45,696	2.2
Exercisable at September 27, 2019	1,511		$	12.77	$	45,696	2.2

The RSU agreement provides for grants of RSUs, 25% of which will vest and be settled in shares on each of the first four anniversaries of the date of grant, subject to the participant's continued employment with the Company through each such anniversary. The grant-date fair value of RSUs is based on the fair value of the Company's common stock. Participants holding RSUs will receive the benefit of any dividends paid on shares in the form of additional RSUs. The unvested units are subject to



Restricted Stock Units	Units (000s)	Weighted Average Grant Date Fair Value
Outstanding at September 28, 2018	2,408	$	36.66
Granted	1,204	$	36.53
Vested	(630)	$	35.49
Forfeited	(333)	$	36.99
Outstanding at September 27, 2019	2,649	$	36.89

Under the 2013 Stock Plan, the Company is authorized to grant PSUs to its employees. A participant is eligible to become vested in a number of PSUs equal to a percentage, higher or lower, of the target number of PSUs granted based on the level of the Company's achievement of the performance condition. During fiscal 2017, the Company granted PSUs subject to the level of achievement of adjusted earnings per share for the cumulative three years performance period and the participant's continued employment with the Company, which vested at the end of fiscal 2019. During both fiscal 2018 and 2019, the Company granted PSUs subject to the level of achievement of adjusted earnings per share and return on invested capital for the cumulative three year performance period and the participant's continued employment with the Company. The grant-date fair value of the PSUs is based on the fair value of the Company's common stock.



Performance Stock Units	Units (000s)	Weighted Average Grant Date Fair Value
Outstanding at September 28, 2018	1,614	$	34.99
Granted⁽³⁾	1,299	$	36.44
Vested	(1,051)	$	32.65
Forfeited	(241)	$	36.66
Outstanding at September 27, 2019	1,621	$	36.20

Deferred Stock Units are issued only to non-employee members of the Board of Directors of the Company and represent the right to receive shares of the Company's common stock in the future. Each deferred stock unit will be converted to one share of the Company's common stock either on the first day of the seventh month after which such director ceases to serve as a member of the Board of Directors or at the director's election upon vesting. The grant-date fair value of deferred stock units is based on the fair value of the Company's common stock. The deferred stock units vest on the day prior to the next annual meeting of stockholders (which is generally one year after grant). The Company granted 58,912 deferred stock units during fiscal 2019. In addition, directors may elect to defer their cash retainer into Deferred Stock Units which are fully vested upon issuance.